Bradford D. Dahms
CIK 1787307 · View on SEC EDGAR ↗
First SEC filing: July 14, 2025 · Latest: July 14, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | JBIO | A | 226,875 | — | — | 226,875 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 12, 2026 | JBIO | A | 37,813 | — | — | 37,813 Direct | — | Acquired | (price as of 2026-08-20) |
| July 14, 2025 | JBIO | A | 526,000 | — | — | 526,000 Direct | — | Acquired | (price as of 2026-08-20) |
| July 1, 2020 | RNAC | A | 40,000 | — | — | 40,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | JBIO | Stock Option (Right to Buy) | Common Stock (226,875) | $14.81 | Feb. 11, 2036 | 226,875 | Acquired |
| July 14, 2025 | JBIO | Stock Option (Right to Buy) | Common Stock (526,000) | $9.00 | July 14, 2035 | 526,000 | Acquired |
| July 1, 2020 | RNAC | Employee Stock Option (right to buy) | Common Stock (40,000) | $2.84 | June 30, 2030 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $183,206 | — | — | $526,588 | — | — | $3,526 | $868,053 |
| 2020 | $370,577 | $25,000 | — | $323,644 | $172,500 | — | $67,635 | $959,356 |
JBIO
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $233,013 | — | — | — | $113,600 | — | $3,438 | $4,131,991 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.